Longevity Peptides
Different senolytic compounds may work better in different tissues, which supports combining agents. The medical view that aging is non-modifiable has shifted toward recognizing it as a modifiable risk factor for virtually all chronic dise…
2 sources - 10 claims
Different senolytic compounds may work better in different tissues, which supports combining agents. The medical view that aging is non-modifiable has shifted toward recognizing it as a modifiable risk factor for virtually all chronic disease. The modern senolytic field accelerated after 2015 with Mayo Clinic and Scripps Institute of Aging research identifying compounds that could selectively help remove senescent cells. Senolytics are compounds that help remove senescent cells by weakening survival networks that let those cells resist death. Aging is increasingly recognized as a modifiable risk factor for all chronic disease, and senolytics represent a direct intervention in that process. Senolytics may help make senescent cells undergo apoptosis or become more available for immune clearance. Epithalon is released from the pineal gland and promotes telomerase production, extending telomere length as a direct mechanism involved in biological aging. Foxo4-DRI is a senolytic peptide that selectively clears senescent cells. MOTS-C is a mitochondria-derived peptide relevant to cellular health broadly, as mitochondria participate in apoptosis, cell signaling, and nuclear communication…